News
The company had reported an EBITDA of ₹1,359 crore during the same period last year. EBITDA margin was at 14.26%, versus ...
Indian pharma giant Cipla released its Q4 FY 25 result, wherein it posted a healthy year-on-year growth of 30% in net profit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback